Additionally, by upregulating the expression of p53 and downregulating the expression of SOX2, Oct-4, Nanog, CD133, and CD44, ALT was able to modify the stemness of prostate cancer cells [112]. This evidence concerns the gene GPT and Familial prostate cancer.